Cargando…
Protective role of beta-blockers in chemotherapy-induced cardiotoxicity—a systematic review and meta-analysis of carvedilol
Some randomized controlled trials (RCTs) have tested the efficacy of beta-blockers as prophylactic agents on cancer therapy-induced cardiotoxicity; however, the quality of this evidence remains undetermined. This systematic review and meta-analysis study aims to evaluate the prophylactic effects of...
Autores principales: | Huang, Shan, Zhao, Qin, Yang, Zhi-gang, Diao, Kai-yue, He, Yong, Shi, Ke, Shen, Meng-ting, Fu, Hang, Guo, Ying-kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476829/ https://www.ncbi.nlm.nih.gov/pubmed/30523513 http://dx.doi.org/10.1007/s10741-018-9755-3 |
Ejemplares similares
-
Carvedilol Versus Other Nonselective Beta Blockers for Variceal Bleeding Prophylaxis and Death: A Network Meta-analysis
por: Cheung, Ka-Shing, et al.
Publicado: (2023) -
Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats
por: Sari, Flori R., et al.
Publicado: (2011) -
Effects of the beta-blocker carvedilol on arrhythmia and long-term clinical outcomes in benign prostate hypertrophy patients
por: Kim, Soo Jin, et al.
Publicado: (2023) -
Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome
por: Wong, Wei-Ting, et al.
Publicado: (2018) -
Preventive use of beta-blockers for anthracycline-induced cardiotoxicity: A network meta-analysis
por: He, Dongsheng, et al.
Publicado: (2022)